Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy

NACompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

pantoprazole+bismuth+tetra+metro

pantoprazole 40 mg twice daily, bismuth subcitrate 120 mg four times daily, and tetracycline 500 mg four times daily, and metronidazole 250 mg four times daily for 14 days

DRUG

(panto+amox+clar+metr)+(panto+amox)

a 7-day quadruple regimen with pantoprazole 40 mg twice daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily, and metronidazole 500 mg twice daily, followed by a 7-day dual regimen with pantoprazole 40 mg twice daily and amoxicillin 1 g twice daily

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER

NCT02547038 - Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy | Biotech Hunter | Biotech Hunter